IRS Code 280E

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

The potential of rescheduling and removing Tax Rule 280E could boost profits for U.S. businesses. However, Zuanic and Associates' latest report reveals complexities and overlooked consequences. What is the best option for unlocking the cannabis industry's potential: exploring...

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report. Re-scheduling Vs. De-scheduling: What Is The Difference? Re-scheduling cannabis refers to the process of...

Section 280e of the Internal Revenue Code has emerged as an unexpected catalyst, potentially injecting a staggering $700 million boost into cash flow for major cannabis companies. The cannabis industry has faced numerous challenges, including falling prices, excessive debt and stagnant sales...

New Jersey Gov. Phil Murphy did the cannabis industry in his state a huge favor when he signed a law decoupling marijuana businesses from federal IRS Code Section 280E, the bane of the industry’s collective existence.  What happened: The legislation, written by New Jersey...